This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (55) Citing Articles via Google Scholar Google Scholar Articles by Morrison, S. G. Articles by Reiz, S. Search for Related Content PubMed PubMed Citation Articles by Morrison, S. G. Articles by Reiz, S.

---

CARDIOVASCULAR ANESTHESIA

A Comparison of the Electrocardiographic Cardiotoxic Effects of Racemic Bupivacaine, Levobupivacaine, and Ropivacaine in Anesthetized Swine

Department of Anesthesiology and Surgical Intensive Care, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

Address correspondence to Stuart G. Morrison, FFARCSI, Department of Anesthesiology, University Hospital of Maastricht, P Debyelaan 25, 6202 AZ Maastricht, The Netherlands. Address e-mail to katrin.mignolet{at}planetinternet.be

We sought, in this observer-blinded study, to determine the lethal dose for each of the local anesthetics levobupivacaine (L), racemic bupivacaine (B), and ropivacaine (R), and to compare their respective effects on the QRS interval of the precordial electrocardiograph after intracoronary injection. Anesthetized swine were instrumented with a left anterior descending artery coronary angiography catheter and injected with increasing doses of L, B, or R according to a randomized protocol. The doses administered were 0.375, 0.75, 1.5, 3.0, and 4.0 mg, with further doses increasing in 1-mg increments until death occurred. Plotting the mean maximum QRS interval as a function of the log₁₀ mmol dose allowed the following cardiotoxicity potency ratios to be determined for a doubling of QRS duration—B:L:R = 2.1:1.4:1. The lethal doses in millimoles (median/range) for L and R were (0.028/0.024–0.031) and (0.032/0.013–0.032), respectively, and were significantly higher than for B (0.015/0.012–0.019) - (P < 0.05, n = 7 for all groups). The lethal dose did not differ between R and L. Thus, the cardiotoxicity potency ratios for the three anesthetics based on lethal dose were: 2.1:1.2:1. If the anesthetic potencies for B and L are similar, the latter should have less potential for cardiotoxicity in the clinical situation.

Implications: Animal experiments have shown levobupivacaine and ropivacaine to be less cardiotoxic than racemic bupivacaine. This in vivo study, using a validated swine model, compared the relative direct cardiotoxicities of these three local anesthetics. The lethal dose did not differ between levobupivacaine and ropivacaine, but was lowest for racemic bupivacaine.

This article has been cited by other articles:

				S. E. Copeland, L. A. Ladd, X.-Q. Gu, and L. E. Mather The Effects of General Anesthesia on the Central Nervous and Cardiovascular System Toxicity of Local Anesthetics Anesth. Analg., May 1, 2008; 106(5): 1429 - 1439. [Abstract] [Full Text] [PDF]

				N. G. B. Chedid, R. T. Sudo, M. I. S. Aguiar, M. M. Trachez, M. O. Masuda, and G. Zapata-Sudo Regulation of intracellular calcium by bupivacaine isomers in cardiac myocytes from wistar rats. Anesth. Analg., March 1, 2006; 102(3): 792 - 798. [Abstract] [Full Text] [PDF]

				T. G. Costello, J. R. Cormack, L. E. Mather, B. LaFerlita, M. A. Murphy, and K. Harris Plasma levobupivacaine concentrations following scalp block in patients undergoing awake craniotomy Br. J. Anaesth., June 1, 2005; 94(6): 848 - 851. [Abstract] [Full Text] [PDF]

				B. Locatelli, P. Ingelmo, V. Sonzogni, A. Zanella, V. Gatti, A. Spotti, S. Di Marco, and R. Fumagalli Randomized, double-blind, phase III, controlled trial comparing levobupivacaine 0.25%, ropivacaine 0.25% and bupivacaine 0.25% by the caudal route in children Br. J. Anaesth., March 1, 2005; 94(3): 366 - 371. [Abstract] [Full Text] [PDF]

				M. W. Hollmann, K. Kurz, S. Herroeder, D. Struemper, K. Hahnenkamp, N. S. Berkelmans, C. G. den Bakker, and M. E. Durieux The Effects of S(-)-, R(+)-, and Racemic Bupivacaine on Lysophosphatidate-Induced Priming of Human Neutrophils Anesth. Analg., October 1, 2003; 97(4): 1053 - 1058. [Abstract] [Full Text] [PDF]

				J. Stewart, N. Kellett, and D. Castro The Central Nervous System and Cardiovascular Effects of Levobupivacaine and Ropivacaine in Healthy Volunteers Anesth. Analg., August 1, 2003; 97(2): 412 - 416. [Abstract] [Full Text] [PDF]

				A. Gupta, S. E. Thorn, K. Axelsson, L. G. Larsson, G. Agren, B. Holmstrom, and N. Rawal Postoperative Pain Relief Using Intermittent Injections of 0.5% Ropivacaine Through a Catheter After Laparoscopic Cholecystectomy Anesth. Analg., August 1, 2002; 95(2): 450 - 456. [Abstract] [Full Text] [PDF]

				M. J. G. Simon, B. T. Veering, R. Stienstra, J. W. van Kleef, and A. G. L. Burm The Effects of Age on Neural Blockade and Hemodynamic Changes After Epidural Anesthesia with Ropivacaine Anesth. Analg., May 1, 2002; 94(5): 1325 - 1330. [Abstract] [Full Text] [PDF]

				E. A. Alley, D. J. Kopacz, S. B. McDonald, and S. S. Liu Hyperbaric Spinal Levobupivacaine: A Comparison to Racemic Bupivacaine in Volunteers Anesth. Analg., January 1, 2002; 94(1): 188 - 193. [Abstract] [Full Text] [PDF]

				C. Glaser, P. Marhofer, G. Zimpfer, M. T. Heinz, C. Sitzwohl, S. Kapral, and I. Schindler Levobupivacaine Versus Racemic Bupivacaine for Spinal Anesthesia Anesth. Analg., January 1, 2002; 94(1): 194 - 198. [Abstract] [Full Text] [PDF]

				M. P. Vercauteren, G. Hans, K. De Decker, and H. A. Adriaensen Levobupivacaine Combined with Sufentanil and Epinephrine for Intrathecal Labor Analgesia: A Comparison with Racemic Bupivacaine Anesth. Analg., October 1, 2001; 93(4): 996 - 1000. [Abstract] [Full Text] [PDF]

				S. Ohmura, M. Kawada, T. Ohta, K. Yamamoto, and T. Kobayashi Systemic Toxicity and Resuscitation in Bupivacaine-, Levobupivacaine-, or Ropivacaine-Infused Rats Anesth. Analg., September 1, 2001; 93(3): 743 - 748. [Abstract] [Full Text] [PDF]

				G. Zapata-Sudo, M. M. Trachez, R. T. Sudo, and T. E. Nelson Is Comparative Cardiotoxicity of S(-) and R(+) Bupivacaine Related to Enantiomer-Selective Inhibition of L-Type Ca2+ Channels? Anesth. Analg., February 1, 2001; 92(2): 496 - 501. [Abstract] [Full Text] [PDF]

				L. Groban, D. D. Deal, J. C. Vernon, R. L. James, and J. Butterworth Cardiac Resuscitation After Incremental Overdosage with Lidocaine, Bupivacaine, Levobupivacaine, and Ropivacaine in Anesthetized Dogs Anesth. Analg., January 1, 2001; 92(1): 37 - 43. [Abstract] [Full Text] [PDF]

				L. Groban, D. D. Deal, J. C. Vernon, R. L. James, and J. Butterworth Ventricular Arrhythmias With or Without Programmed Electrical Stimulation After Incremental Overdosage with Lidocaine, Bupivacaine, Levobupivacaine, and Ropivacaine Anesth. Analg., October 1, 2000; 91(5): 1103 - 1111. [Abstract] [Full Text] [PDF]